Cite
MLA Citation
Jeffrey Cummings et al.. “P3–278: The rivastigmine high‐dose, 13 mg/24h (15cm2), transdermal patch provides daily living benefits to people with severe Alzheimer's disease: Retrospective analyses of the OPtimising Transdermal Exelon In Mild‐to‐moderate Alzheimer's disease (OPTIMA) study.” Alzheimer's & dementia, vol. 9, n.d., p. P658. http://access.bl.uk/ark:/81055/vdc_100103416092.0x000022